JNJ Filing
4Filing Date: Jun 12, 2026

JOHNSON & JOHNSON (JNJ) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000200406-26-000127open_in_new
Total Value$3.57M
Trades4
Insiders1

Transaction Details

Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$241.15
Total Value$2.41M
Shares Owned After114.29K
Transaction DateJun 11, 2026
Footnotes ▸

This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Exercise · Acquire
Common Stock
Shares+10.00K
Price$115.67
Total Value$1.16M
Shares Owned After124.29K
Transaction DateJun 11, 2026
Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Exercise · Dispose
Employee Stock Options (Right to Buy)Derivative
Shares-10.00K
Price$0.00
Total Value$0
Shares Owned After32.97K
Transaction DateJun 11, 2026
ExpiresFeb 13, 2027
Footnotes ▸

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Wengel Kathryn E
EVP, Chief TO and Risk Officer·Indirect · By ESOP
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After281
Footnotes ▸

Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).

Post-Transaction Holdings

Wengel Kathryn E
SecuritySharesChange
Common Stock114.57K-
Employee Stock Options (Right to Buy)32.97K-10.00K (-23.27%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: JOHNSON & JOHNSON (JNJ) CIK: 0000200406 --- Reporting Owner --- Name: Wengel Kathryn E CIK: 0001745955 Role: Officer (EVP, Chief TO and Risk Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-11 | Code: M (Exercise of derivative) Shares: +10,000 | Price: $115.67 Total Value: $1,156,700.00 Shares Owned After: 124,287.8735 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-06-11 | Code: S (Open market sale) Shares: -10,000 | Price: $241.15 Total Value: $2,411,500.00 Shares Owned After: 114,287.8735 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Options (Right to Buy) Date: 2026-06-11 | Code: M (Exercise of derivative) Shares: -10,000 | Price: $0.00 Exercisable: N/A | Expires: 2027-02-13 Shares Owned After: 32,965 | Ownership: D (Direct) Footnotes: [F4] Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) Footnotes: [F2] Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). [Holding #2] Security: Common Stock Ownership: I (Indirect) Footnotes: [F3] Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). F4: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. --- Signature --- /s/ /s/ Joleen Morgan, as attorney-in-fact for Kathryn E. Wengel (2026-06-12)

keid AI analysis is for reference only and does not constitute investment advice.